CFO Christopher Scully plays an instrumental role in helping accelerate Cordis’ growth as it establishes itself as a technological leader. 

Most recently, Mr. Scully was Executive Vice President and Chief Financial Officer for PPD, where he worked with leaders across the enterprise to meet or exceed the company’s financial targets for four consecutive years and deliver double-digit growth. He played an instrumental role in the company’s IPO and, ultimately, its sale to Thermo Fisher Scientific for an enterprise value greater than $20 Billion. Prior to his tenure with PPD, he served more than 20 years with Pfizer. 

Mr. Scully earned his MBA at NYT Stern School of Business and attended the Harvard Business School Pfizer Leadership Development Program. He received a B.E. from Manhattan College.